UBS YIELD OPTIMIZATION NOTES INVESTMENT LOSSES

The Soreide Law Group is investigating claims on behalf of investors purchasing UBS Yield Optimization Notes. UBS’ Yield Optimization Notes are also known as reverse convertibles. Reverse convertibles are esoteric structured products based upon the performance of a short put option, or derivative. Reverse convertibles are attractive to investors seeking income because of the above average income the product provides. However, this income product has substantial risk of loss of principal. The income comes from the premium received from the sale of a put on the underlying stock. Surprisingly, UBS does not mandate its registered representatives to perform option suitability analysis or have investors fill out options account forms. As a result, investors, including retirees, without options investing experience can been sold complicated option laden reverse convertibles.

UBS is one of several firms that are under investigation by the State of Georgia for improper reverse convertible sales. Georgia securities regulators are not alone, the State of Massachusetts is also investigating how firms are selling reverse convertibles to investors. The SEC is also investigating whether the risks and fees of reverse convertibles were properly disclosed to investors. In addition, the SEC is investigating whether investors overpaid for reverse convertibles. Recognizing potential sales abuses associated with reverse convertibles, FINRA issued Notice to Members 10-09, which was a reminder to firms of their disclosure obligations under NTM 05-59. Members are required to provide balanced risk disclosures to investors purchasing reverse convertibles. In 2011, FINRA began conducting regulatory sweeps to monitor how members were selling reverse convertibles to investors. FINRA has subsequently issued NTM 12-03 which seeks heightened supervision for complex products such as reverse convertibles.

If you or a loved on has purchased UBS Yield Optimization Notes or a reverse convertible product call Lars K. Soreide of the Soreide Law Group at 888-760-6552 for a free consultation or visit https://www.securitieslawyer.com.

Recent Posts

July 11, 2026

Cambridge Investment Research Sanctioned By FINRA Over UIT Recommendations

Soreide Law Group is investigating potential investor claims involving Cambridge Investment Research following a FINRA disciplinary action concerning Unit Investment Trust (UIT) recommendations. In April 2026, FINRA censured Cambridge Investment Research after finding supervisory deficiencies involving certain UIT recommendations made to retail clients. Investors who incurred excessive fees, unnecessary costs, or other damages associated with […]

July 10, 2026

Infinity Financial Services Sanctioned By FINRA Over Variable Annuity Supervision Failures

Soreide Law Group is investigating potential investor claims involving Infinity Financial Services after FINRA sanctioned the firm for supervisory failures involving deferred variable annuity exchanges and recommendations. Investors who incurred surrender charges or other losses in connection with variable annuity transactions recommended through Infinity should review the allegations that led to FINRA's disciplinary action against […]

July 10, 2026

NextGenTech Investments LLC Losses?

Soreide Law Group is investigating potential investor claims involving losses in NextGenTech Investments LLC, a private fund managed by Sestante Capital LLC that purported to provide investors with economic exposure to shares of private companies, including Anduril Industries. Recent criminal proceedings involving Sestante Capital's manager have raised significant concerns regarding the offering, the representations made […]

Contact us Nationwide USA

2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062

Phone: 1-888-760-6552
Fax: 1-954-760-6553
Email: info@securitieslawyer.com

Helping clients recover money across the USA